About Us
At gmp-orphan, we are driven to find innovative solutions for the unmet needs of patients with rare diseases
Who We Are.
At gmp-orphan (GMPO), it is our mission to identify, develop and provide access to innovative treatments to patients with rare diseases. Our experienced pharmaceutical development and commercial team in the field of rare diseases is critical in advancing this mission.
gmp-orphan (GMPO) was founded in 2011 and the company’s most advanced product candidate is Cuprior for the treatment of Wilson’s Disease. Find Out More
Our Executive Team
Board of Directors
Our Investors
GMPO Executive team
GMPO Board of Directors
Investors
gmp-orphan (GMPO) is proud to be supported by a group of leading investors whose shared vision to create a business that delivers medicines of exceptional benefit to patients in areas of high unmet need.
Get In Touch
Find out more about GMPO, who we are and what we do.
